Natick, MA R.W. Holmes has negotiated seven lab leases totaling 108,158 s/f of space in Burlington, Natick, and Waltham in Q2 2022.

Elizabeth Holmes, R.W. Holmes’ director of corporate services, said, “We expanded our Life Science team in Greater Boston to meet the urgent needs of startups, private companies, and landlords seeking to convert their properties into labs. Being hands-on and finding creative solutions has been our strength in this niche. Tenants and landlords have praised the team’s innovative approach and our willingness to go the extra mile.”

Snap Dragon Chemistry expanded its lease at Waltham Research Park, located at 360 Second Ave.?Senior vice president, Arthur Amadei of R.W. Holmes served as the exclusive leasing agent for the landlord, Hillside Associates.?

Boston Dynamics signed a new lease for 23,300 s/f at Waltham Research Park. Amadei handled the transaction on behalf of Hillside Associates. Boston Dynamics was represented by CBRE and Colliers.

Boston Lab Services has signed a new flex lease at 18 Terry Ave. in Burlington for 10,500 s/f.?Assistant vice president Mike Ogasapian of R.W. Holmes represented Boston Lab Services and the landlord, Rose Realty Partners.

Adden Energy has signed a new lease for 6,745 s/f at 1432 Main St. in Waltham to develop and scale an entirely new type of solid-state battery.?Holmes and Craig Johnston, senior vice president of R.W. Holmes, represented Adden Energy.

AmberGen, Inc. leased 6,448 s/f of space at 425 Waverly Oaks Rd. in Waltham. R.W. Holmes, managing director Dean Blackey, and Holmes represented the tenant in the transaction.

Geneius Biotechnology expanded its lease to 3,710 s/f of space at 12 Michigan Dr. in Natick. Johnston represented both parties.

Inmunoracle leased and expanded to 5,700 s/f of space at 12 Michigan Dr. in Natick. Johnston represented both parties in this deal as well.

“We are extremely proud to have assisted so many amazing life science companies this quarter and look forward to helping more tenants and landlords in the future,” said Ogasapian. “There is a persistent, unmet demand for lab space from early-stage and privately-held lab users under 20,000 s/f.”